Investing.com -- Shares of Madrigal Pharmaceuticals, Inc. ( NASDAQ: NASDAQ: MDGL) rose 17% following the announcement of their fourth-quarter and full-year 2024 financial results, which included a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback